Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $303.87 million. The enterprise value is $210.17 million.

Market Cap	303.87M
Enterprise Value	210.17M

Important Dates

The next estimated earnings date is Wednesday, August 5, 2026, after market close.

Earnings Date	Aug 5, 2026
Ex-Dividend Date	n/a

Share Statistics

NMRA has 185.28 million shares outstanding. The number of shares has increased by 4.83% in one year.

Current Share Class	185.28M
Shares Outstanding	185.28M
Shares Change (YoY)	+4.83%
Shares Change (QoQ)	+6.74%
Owned by Insiders (%)	4.46%
Owned by Institutions (%)	38.02%
Float	113.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.23
P/TBV Ratio	4.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.76.

Current Ratio	5.09
Quick Ratio	4.88
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-42.99

Financial Efficiency

Return on equity (ROE) is -148.74% and return on invested capital (ROIC) is -77.15%.

Return on Equity (ROE)	-148.74%
Return on Assets (ROA)	-66.39%
Return on Invested Capital (ROIC)	-77.15%
Return on Capital Employed (ROCE)	-176.21%
Weighted Average Cost of Capital (WACC)	17.64%
Revenue Per Employee	n/a
Profits Per Employee	-$2.42M
Employee Count	92
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $55,000 in taxes.

Income Tax	55,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +103.00% in the last 52 weeks. The beta is 2.76, so NMRA's price volatility has been higher than the market average.

Beta (5Y)	2.76
52-Week Price Change	+103.00%
50-Day Moving Average	1.88
200-Day Moving Average	2.19
Relative Strength Index (RSI)	49.03
Average Volume (20 Days)	4,192,463

Short Selling Information

The latest short interest is 4.92 million, so 2.65% of the outstanding shares have been sold short.

Short Interest	4.92M
Short Previous Month	5.58M
Short % of Shares Out	2.65%
Short % of Float	4.32%
Short Ratio (days to cover)	2.83

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-218.08M
Pretax Income	-222.34M
Net Income	-222.39M
EBITDA	-218.03M
EBIT	-218.08M
Earnings Per Share (EPS)	-$1.32

Full Income Statement

Balance Sheet

The company has $147.07 million in cash and $53.37 million in debt, giving a net cash position of $93.70 million or $0.51 per share.

Cash & Cash Equivalents	147.07M
Total Debt	53.37M
Net Cash	93.70M
Net Cash Per Share	$0.51
Equity (Book Value)	70.68M
Book Value Per Share	0.39
Working Capital	123.32M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-193.40M
Capital Expenditures	n/a
Depreciation & Amortization	59,000
Net Borrowing	57.16M
Free Cash Flow	-193.40M
FCF Per Share	-$1.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.83%
Shareholder Yield	-4.83%
Earnings Yield	-73.19%
FCF Yield	-63.65%

Analyst Forecast

The average price target for NMRA is $6.53, which is 298.17% higher than the current price. The consensus rating is "Buy".

Price Target	$6.53
Price Target Difference	298.17%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1